Skip to content

Clinical trials

Phase 2 Prostatic Neoplasms trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prostatic Neoplasms Phase: Phase 2 Country / region: Belgium Clear all

43 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20033
20043
20051
20062
20071
20081
20092
20101
20112
20122
20133
20142
20162
20173
20183
20193
20202
20211
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed28
Unknown status5
Active, not recruiting4
Terminated3
Recruiting1
Not yet recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University Hospital, Ghent7
European Organisation for Research and Treatment of Cancer - EORTC5
Astellas Pharma Inc4
AstraZeneca3
Universitaire Ziekenhuizen KU Leuven3
Centocor, Inc.2
Ferring Pharmaceuticals2
Astellas Pharma Global Development, Inc.1
Bayer1
Cancer Research Antwerp1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Neoplasms43
Neoplasm Metastasis6
Breast Neoplasms3
Carcinoma, Non-Small-Cell Lung3
Neoplasms3
Ovarian Neoplasms3
Pancreatic Neoplasms3
Endometrial Neoplasms2
Melanoma2
Stomach Neoplasms2

Trials

Showing 1 to 25 of 43. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.